Are you a new member? Sign up now
Login area
| Sign up
close
REVOLADE - 25mg - 28
| ATC | B/G | Ingredients | code | Registration Nb | Name | Dosage | Presentation | Form | Route | Agent | Laboratory | Country | Price | Pharmacist Margin | Stratum | Responsible Party Name | Responsible Party Country | Exch_date | %SUBSIDY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| B02BX05 | B | Eltrombopag Olamine - 25mg | 11625/945 | 120416/1 | REVOLADE | 25mg | 28 | Tablet, film coated | Oral | Khalil Fattal & Fils S.A.L. | Lek Pharmaceuticals dd | Slovenia | 78,295,560 L.L | 10.71 | E1 | Novartis Pharma AG | Switzerland | 05/02/20 | 0 |
Drugs With Same Ingredients
| ATC | B/G | Ingredients | code | Registration Nb | Name | Dosage | Presentation | Form | Route | Agent | Laboratory | Country | Price | Pharmacist Margin | Stratum | Responsible Party Name | Responsible Party Country | Exch_date | %SUBSIDY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| B02BX05 | B | Eltrombopag Olamine - 25mg | 8790 | 120416/1 | REVOLADE | 25mg | 28 | Tablet, film coated | Oral | Khalil Fattal & Fils S.A.L. | Siegfried Barbera SL | Spain | 1,284,239 L.L | 10.71 | E1 | Novartis Pharma AG | Switzerland | 05/02/20 | |
| B02BX05 | B | Eltrombopag Olamine - 25mg | 11625 | 120416/1 | REVOLADE | 25mg | 28 | Tablet, film coated | Oral | Khalil Fattal & Fils S.A.L. | Lek Pharmaceuticals dd | Slovenia | 1,284,239 L.L | 10.71 | E1 | Novartis Pharma AG | Switzerland | 05/02/20 | |
| B02BX05 | B | Eltrombopag Olamine - 25mg | 8790/945 | 120416/1 | REVOLADE | 25mg | 28 | Tablet, film coated | Oral | Khalil Fattal & Fils S.A.L. | Siegfried Barbera SL | Spain | 78,295,560 L.L | 10.71 | E1 | Novartis Pharma AG | Switzerland | 05/02/20 | 0 |
Sitemap
© Copyrights reserved to Ministry of Public Health 2024